The long awaited arrival of Celera Genomics' Taiwan branch kicked off yesterday with the company, formerly billed as Celera Asia, being officially renamed Vita Genomics Inc (
Established in Taiwan with an eye for focusing on Asian specific genetic research, Vita Genomics plans to carry out gene sequencing in order to identify genes related to diseases common in Asia, such as liver and nasal cancer.
Ellson Chen (
The new company will be housed in the Taipei Biotechnology Park (台北生技園區) until construction is completed on its primary research center in the Tainan Science-based Industrial Park (台南科學園區). Once the Tainan location comes on line, the Taipei office will remain open as a branch office only. The company also opened a branch in Burlingame, California to handle bioinformatic research.
Although Vita's intended purpose and management team remain the same as previously reported, some of its strategies have changed.
Originally, Vita officials planned to raise NT$3.5 billion (US$100 million) to capitalize the venture, with major stakes going to Ho Tung Chemical, President Enterprises (
According to an anonymous source close to the situation, Celera is now part of the Vita deal with a US$5 million investment -- stock shares traded in return for unlimited access to Celera's extensive genetic database. (Originally, Celera was to invest up to 20 percent of the US$100 million needed to establish the company.)
Apparently, the management at Vita did not want Celera to have a seat on the company's board of directors "to prevent a potential future conflict" in the event that the two firms eventually become fierce competitors, the insider said.
Investors who have put up Vita's current financing include Ho Tung Chemical, China Development Industrial Bank (中華開發工銀), Cathay Life Insurance Co Ltd (國泰人壽), National Securities Corp (建弘證券) and the Executive Yuan's Development Fund (開發基金).
The arrival of Vita Genomics sent the stock of one of its prime investors, Ho Tung Chemical, up above 100 percent over the course of the year, doubling since Jan. 2 when it opened at NT$13.2.
In its last few sessions, the stock has gone on a wild ride. Last Friday, the stock price rose 6.15 percent in heavy trading, as 19.6 million shares of Ho Tung stock changed hands, far more than a normal trading day for the stock. Yesterday, the stock dropped 3 percent to NT$26.5, and analysts said the Friday session indicated that investors thought yesterday's announcement might be positive for the stock.
To highlight the importance officials place on the addition of Vita Genomics to Taiwan's biotechnology industry, the meeting held yesterday to introduce the firm attracted heavy hitters from Taiwan's biotech sector, including Academia Sinica (
PROTECTIONISM: China hopes to help domestic chipmakers gain more market share while preparing local tech companies for the possibility of more US sanctions Beijing is stepping up pressure on Chinese companies to buy locally produced artificial intelligence (AI) chips instead of Nvidia Corp products, part of the nation’s effort to expand its semiconductor industry and counter US sanctions. Chinese regulators have been discouraging companies from purchasing Nvidia’s H20 chips, which are used to develop and run AI models, sources familiar with the matter said. The policy has taken the form of guidance rather than an outright ban, as Beijing wants to avoid handicapping its own AI start-ups and escalating tensions with the US, said the sources, who asked not to be identified because the
Taipei is today suspending its US$2.5 trillion stock market as Super Typhoon Krathon approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed-income trading, statements from its stock and currency exchanges said. Yesterday, schools and offices were closed in several cities and counties in southern and eastern Taiwan, including in the key industrial port city of Kaohsiung. Taiwan, which started canceling flights, ship sailings and some train services earlier this week, has wind and rain advisories in place for much of the island. It regularly experiences typhoons, and in July shut offices and schools as
FALLING BEHIND: Samsung shares have declined more than 20 percent this year, as the world’s largest chipmaker struggles in key markets and plays catch-up to rival SK Hynix Samsung Electronics Co is laying off workers in Southeast Asia, Australia and New Zealand as part of a plan to reduce its global headcount by thousands of jobs, sources familiar with the situation said. The layoffs could affect about 10 percent of its workforces in those markets, although the numbers for each subsidiary might vary, said one of the sources, who asked not to be named because the matter is private. Job cuts are planned for other overseas subsidiaries and could reach 10 percent in certain markets, the source said. The South Korean company has about 147,000 in staff overseas, more than half
Her white-gloved, waistcoated uniform impeccable, 22-year-old Hazuki Okuno boards a bullet train replica to rehearse the strict protocols behind the smooth operation of a Japanese institution turning 60 Tuesday. High-speed Shinkansen trains began running between Tokyo and Osaka on Oct. 1, 1964, heralding a new era for rail travel as Japan grew into an economic superpower after World War II. The service remains integral to the nation’s economy and way of life — so keeping it dazzlingly clean, punctual and accident-free is a serious job. At a 10-story, state-of-the-art staff training center, Okuno shouted from the window and signaled to imaginary colleagues, keeping